Need professional-grade analysis? Visit stockanalysis.com
$30.20B
13.84
2,201
1.94%
Giant Biogene Holding Co Ltd (2367) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Consumer Defensive sector under the Household & Personal Products industry. The stock currently trades at HKD28.76, down 1.44% from the previous close.
Over the past year, 2367 has traded between a low of HKD27.50 and a high of HKD83.95. The stock has lost 62.1% over this period. It is currently 65.7% below its 52-week high.
Giant Biogene Holding Co Ltd has a market capitalization of $30.20B, with a price-to-earnings ratio of 13.84 and a dividend yield of 1.94%.
Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, manufactures, and sells skin treatment products with recombinant collagen in the People's Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company provides its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
Side-by-side comparison against top Consumer Defensive peers.